Pfizer

Yahoo Finance • yesterday

North America Biotechnology Research and Market Dynamics Report 2025-2033

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "North America Biotechnology Market Report by Product Type, Technology, Application, Countries and Company Analysis 2025-2033" report has been added to ResearchAndMarkets.com's offering.... Full story

Yahoo Finance • 2 days ago

Novo Nordisk or Pfizer: Which Healthcare Giant Is the Better Bet?

Novo Nordisk NVO and Pfizer PFE are pharmaceutical giants based in Denmark and the United States, respectively, with strong leadership positions in distinct therapeutic areas. NVO is widely recognized as the market leader in the GLP-1 spac... Full story

Yahoo Finance • 2 days ago

Tissue Factor-Targeted Immunotherapies Pipeline and Competitive Intelligence Report 2025: Tivdak Has Become the Benchmark for Improved Next Generation ADCs in Non-clinical and Clinical Development

Dublin, Nov. 27, 2025 (GLOBE NEWSWIRE) -- The "Pipeline of Tissue Factor-Targeted Immunotherapies" report has been added to ResearchAndMarkets.com's offering. This competitive intelligence report about Tissue Factor-Targeted Immunoth... Full story

Yahoo Finance • 3 days ago

CMS unveils price reductions for 15 drugs for 2027

[Pills and money] txking/iStock via Getty Images Individuals covered under Medicare can expect significant savings on the 15 drugs that were selected earlier this year for drug price negotiations under the Inflation Reduction Act starting... Full story

Yahoo Finance • 3 days ago

Goitre Market Report 2025: Global, Regional and Country-Level Trends Analysis with Growth Projections to 2035

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Goitre Market - A Global and Regional Analysis: Focus on Country and Region - Analysis and Forecast, 2025-2035" has been added to ResearchAndMarkets.com's offering. The goitre market is... Full story

Yahoo Finance • 3 days ago

Nanotechnology Drug Delivery Market Projected to Reach USD 200.77 Billion by 2032, Owing to Prevalence of Chronic Diseases & Advances in Nanomedicine – SNS Insider

Austin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Nanotechnology Drug Delivery Market Size & Growth Analysis According to a SNS Insider, the Nanotechnology Drug Delivery Market size was valued at USD 96.39 billion in 2024 and is projected to re... Full story

Yahoo Finance • 3 days ago

Gene Therapy Collaboration and Licensing Agreements Trends Analysis Report 2025 with Directory of 787 Deals Signed Since 2016 by Company A-Z, Therapy Focus and Technology Type

Dublin, Nov. 26, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive listing of 787 gene therapy deals anno... Full story

Yahoo Finance • 3 days ago

Stocks to Watch Wednesday: Dell, HP, Workday, Li Auto

↗️ Dell (DELL): The computer and software maker raised full-year guidance and forecast AI server shipments would more than double. Shares rose nearly 5% premarket. ↘️ HP (HPQ): The computer and printer maker plans to cut up to 10% of its w... Full story

Yahoo Finance • 4 days ago

Vaccine critic selected as CDC deputy director

[CDC Headquarters] hapabapa Ralph Abraham, Louisiana's surgeon general, is the CDC's next deputy director. _The Washington Post_, which broke [https://www.washingtonpost.com/health/2025/11/25/cdc-new-deputy-vaccine-ralph-abraham/] the de... Full story

Yahoo Finance • 4 days ago

Fluence Energy targets $3.2B–$3.6B FY26 revenue with 85% backlog coverage as data center demand surges

Earnings Call Insights: Fluence Energy (FLNC) Q4 2025 MANAGEMENT VIEW * CEO Julian Jose Marquez opened by highlighting a record $1.4 billion of orders in the fourth quarter, bringing the backlog to $5.3 billion and positioning the comp... Full story

Yahoo Finance • 4 days ago

US, UK nearing drug prices deal - report

[United States of America and United Kingdom Flags. 3d Rendering] klenger/iStock via Getty Images * The US and UK governments are said to be close to a deal that would boost prices of prescription drugs in the UK in exchange for avoidin... Full story

Yahoo Finance • 4 days ago

PD-1 Resistant Head and Neck Cancer Market Research Report 2025-2030: Cracking the Code of Immunotherapy Resistance - How Sox9 and Anxa1 Shape the Tumor-Immune Standoff

Dublin, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The "PD-1 Resistant Head and Neck Cancer - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for PD-1 Resistant Head and Neck Can... Full story

Yahoo Finance • 4 days ago

PFE Quantitative Stock Analysis

Below is Validea's guru fundamental report for PFIZER INC (PFE). Of the 22 guru strategies we follow, PFE rates highest using our Shareholder Yield Investor model based on the published strategy of Meb Faber. This strategy looks for compa... Full story

Yahoo Finance • 4 days ago

Alphabet Reaches Analyst Target Price

In recent trading, shares of Alphabet Inc (Symbol: GOOG) have crossed above the average analyst 12-month target price of $168.33, changing hands for $173.69/share. When a stock reaches the target an analyst has set, the analyst logically... Full story

Yahoo Finance • 5 days ago

Moderna is the S&P 500's most shorted stock: Here's why

President Trump is expected to unveil plans to lower healthcare costs, which could significantly impact the pharmaceutical industry. Additionally, Pfizer's (PFE) entry into the weight-loss drug space, joining Novo Nordisk (NVO) and Eli Lil... Full story

Yahoo Finance • 5 days ago

Top pharmaceutical stocks by Quant to focus on as Novo Nordisk slides

[Close-up of a male hand holding a pill bottle pouring medication into his hand] Trevor Williams The recent news [https://seekingalpha.com/news/4525254-novo-nordisk-slides-as-ozempic-pill-fails-to-slow-alzheimers-disease-progression-in-la... Full story

Yahoo Finance • 5 days ago

Urinary Tract Infection Treatment Market Competitor Analysis Report 2025: Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue

Dublin, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The "Competitor Analysis of Urinary Tract Infection Treatment Market, Forecast by Recent Developments, Strategy, Sustainability Benchmarking, Product Launch, Key Persons and Revenue" report has b... Full story

Yahoo Finance • 5 days ago

Bristol Myers Pops On A 'Surprisingly Positive' Update From Key Rival Bayer

Bayer issued a "surprisingly positive" report for its blood thinner over the weekend, prodding Bristol Myers Squibb stock higher on Monday. Continue Reading View comments... Full story

Yahoo Finance • 5 days ago

RVL Pharmaceuticals Announces Leadership Appointments to Accelerate Next Phase of Growth and Commercial Momentum

BRIDGEWATER, N.J., Nov. 24, 2025 /PRNewswire/ -- RVL Pharmaceuticals, Inc and its affiliates (together, "RVL") today announced a series of senior leadership appointments to strengthen the organization and position the company for accelerat... Full story

Yahoo Finance • 5 days ago

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

NEW HAVEN, Conn., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that multiple abstracts on vepd... Full story